Retension Pharmaceuticals, Inc.
Public company- Headquarters
- MCLEAN, Virginia
- Ticker
- RTSN
- CIK
- 0002002988
WARN notices since 2024
Workers affected since 2024
Executive changes, last 12 months
Last event
Workers affected over time
Cumulative workers in WARN notices since 2024
Not enough notices to chart yet.
Leadership
| Role and person | Since | Change |
|---|---|---|
| Vice President, Chief Accounting Officer (Principal Accounting Officer)Robert Wong | Oct 23, 2026 | Appointed |
Related companies
Same industry and state, with recent events.
- BRISTOL MYERS SQUIBB CO
WARN notice: Princeton, NJ
- JOHNSON & JOHNSON
WARN notice: New Brunswick, NJ
- Merck & Co., Inc.
WARN notice: Rahway, NJ
- NOVO NORDISK A S
WARN notice: Plainsboro, NJ
- Executive appointment
Vice President, Chief Accounting Officer (Principal Accounting Officer) appointed: Robert Wong
Robert Wong was named Vice President, Chief Accounting Officer (Principal Accounting Officer) of Retension Pharmaceuticals, Inc., effective November 2, 2026. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Oct 23, 2026Role: Vice President, Chief Accounting Officer (Principal Accounting Officer)
Only one public record so far. We add events as soon as a new filing lands; watch Retension Pharmaceuticals, Inc. to get them in your digest.
Last verified Nov 8, 2026